Dengue - Sample Collection Study Pakistan

ConditionDengue

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age12+

SponsorAbbott Rapid Dx

About this trial

The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age ≥12-years-old

Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial.

Disqualifiers

Subject has been vaccinated for dengue.

Subject participates in an investigative drug, vaccine or medical device clinical study

Participant is deemed unfit for the study by the Investigator

Participant is unwilling or unable to provide informed consent

Trial population

Subjects with symptoms suggestive of active dengue or a recent diagnosis of dengue seeking clinical care.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

200 Participants

are grouped into 2 trial groups

Group A: dengue positives

Group B: dengue negatives

Trial outcomes

Primary outcomes

sample collection only, no specific outcome needed

Time frame

5 months

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Abbott Rapid Dx

Lead sponsor

Aga Khan University

Collaborator

National University of Medical Sciences, Pakistan